Manufacturer of Controlled Substances; Notice of Registration, 13822-13823 [E7-5386]

Download as PDF 13822 Federal Register / Vol. 72, No. 56 / Friday, March 23, 2007 / Notices 11. Mescalero National Fish Hatchery, New Mexico. 12. Sequoyah National Wildlife Refuge, Oklahoma. 13. Tishomingo National Wildlife Refuge, Oklahoma. 14. Bandon Marsh National Wildlife Refuge, Washington. 15. Dungeness National Wildlife Refuge, Washington. 16. Makah National Fish Hatchery, Washington. 17. Nisqually National Wildlife Refuge, Washington. 18. Quinalt National Fish Hatchery, Washington. 19. San Juan Islands National Wildlife Refuge, Washington. V. Programmatic Targets During Fiscal Year 2007, upon request of a self-governance tribe, the Fish and Wildlife Service will negotiate funding agreements for its eligible programs beyond those already negotiated. Dated: March 6, 2007. David Verhey, Acting Assistant Secretary for Fish and Wildlife and Parks. [FR Doc. E7–5343 Filed 3–22–07; 8:45 am] BILLING CODE 4310–55–P DEPARTMENT OF THE INTERIOR Bureau of Land Management [NV–912–07–1220PA–006F] Cancellation of the BLM Nevada Resource Advisory Council Recreation Subcommittee Meeting Bureau of Land Management, Interior. ACTION: Cancellation of the BLM Nevada Resource Advisory Council Recreation Subcommittee Meeting. sroberts on PROD1PC70 with NOTICES AGENCY: SUMMARY: The March 29, 2007, meeting of the Bureau of Land Management’s (BLM) Resource Advisory Councils Recreation Subcommittee has been cancelled. DATE AND TIME: The Recreation Subcommittee was scheduled to meet Thursday, March 29, 2007, from 9 a.m. to 4:30 p.m. at the Bureau of Land Management, Nevada State Office, located at 1340 Financial Boulevard in Reno, Nevada. FOR FURTHER INFORMATION CONTACT: Doran Sanchez, Chief, Office of Communications (775) 861–6586, or Barbara Keleher, Outdoor Recreation Planner (775) 861–6628, at the BLM Nevada State Office, 1340 Financial Blvd., Reno, Nevada. SUPPLEMENTARY INFORMATION: The meeting announced by a notice at 72 FR VerDate Aug<31>2005 17:56 Mar 22, 2007 Jkt 211001 9580 Mar. 2, 2007 is cancelled. The public will be notified via Federal Register Notice and news release when the meeting is rescheduled. Dated: March 12, 2007. Ron Wenker, Bureau of Land Management, Nevada State Director. [FR Doc. 07–1288 Filed 3–22–07; 8:45 am] BILLING CODE 4310–HC–M DEPARTMENT OF JUSTICE Notice of Lodging of United States v. MFS, INC., (A/K/A Mineral Fiber Specialists), Civil Action No. 05–6656, (E.D. PA.) Under the Clean Air Act Notice is hereby given that on March 9, 2007 a proposed Consent Decree United States v. MFS, Inc., (a/k/a Mineral Fiber Specialists), Civil Action No. 05–6656, (E.D. Pa.) was lodged with the United States District Court for the Eastern District of Pennsylvania. In this action the United States sought injunctive relief and civil penalties pursuant to Section 113(b) of the Clean Air Act, as amended (‘‘CAA’’) 42 U.S.C. 7413(b), for alleged violations by Defendant MFS, Inc. of Section 112 of the CAA, 42 U.S.C. 7412, and the applicable requirements of 40 CFR part 63, subpart DDD. Defendant MFS, Inc. owns and operates a mineral wool production plant in the City of Bethlehem, Northampton County, Pennsylvania and is therefore subject to National Emission Standards for Hazardous Air Pollutants (‘‘NESHAP’’) for mineral wool manufacturers codified at 40 CFR part 63, subpart DDD (‘‘Mineral Wool or MW NESHAP’’), specifically §§ 63.1175–63.1196. The Consent Decree requires the performance of injunctive relief including initial performance testing of the MFS facility, stipulated penalties for violations of Decree requirements and the payment of a civil penalty to the United States in the amount of $109,000. The Decree authorizes MFS to use an alternative test protocol set forth in Appendix A to the Decree to determine compliance with the particulate matter (‘‘PM’’) emission limits set forth in the Mineral Wool NESHAP, set forth in 40 CFR subpart DDD. If EPA determines that MFS has not complied with the NESHAP, the Decree requires MFS to further submit a plan to achieve compliance with the NESHAP subject to EPA review and approval. The Decree provides for stipulated penalties for noncompliance with the Decree requirements. The Department of Justice will receive for a period of thirty (30) days from the PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 date of this publication comments relating to the lodged Consent Decree. Comments should be addressed to the Assistant Attorney General, Environment and Natural Resources Division, and either e-mailed to pubcomment-ees.enrd@usdoj.gov or mailed to P.O. Box 7611, and should refer to United States v. MFS, Inc. (a/k/a Mineral Fiber Specialists), Civil Action No. 05–6656 (E.D. Pa). The Consent Decree may be examined at the Office of the United States Attorney for the Eastern District of Pennsylvania in Philadelphia, Pennsylvania, and at U.S. EPA Region III in Philadelphia, Pennsylvania. During the public comment period, the Decree may also be examined on the following Department of Justice Web site, http://www.usdoj.gov/enrd/ Consent_Decrees.html. A copy of the Decree may also be obtained by mail from the Consent Decree Library, P.O. Box 7611, U.S. Department of Justice, Washington, DC 20044–7611 or by faxing or e-mailing a request to Tonia Fleetwood (tonia.fleetwood@usdoj.gov), fax no. (202) 514–0097, phone confirmation number (202) 514–1547. In requesting a copy from the Consent Decree Library, please enclose a check in the amount of $9 (5 cents per page reproduction cost) payable to the U.S. Treasury or, if by e-mail or fax, forward a check in that amount to the Consent Decree Library at the stated address. Virginia Gibson, Chief, Civil Division, United States Attorney’s Office, Eastern District of Pennsylvania. [FR Doc. 07–1429 Filed 3–22–07; 8:45 am] BILLING CODE 4410–15–M DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated November 28, 2006, and published in the Federal Register on December 7, 2006, (71 FR 70985), Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I: Drug Marihuana (7360) ......................... Tetrahydrocannabinols (7370) ..... E:\FR\FM\23MRN1.SGM 23MRN1 Schedule I I 13823 Federal Register / Vol. 72, No. 56 / Friday, March 23, 2007 / Notices The company plans to manufacture small quantities of marihuana derivatives for research purposes. In reference to drug code 7360 (Marihuana), the company plans to bulk manufacture cannabidiol. In reference to drug code 7370 (Tetrahydrocannabinols), the company will manufacture a synthetic THC. No other activity for this drug code is authorized for this registration. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cayman Chemical Company to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Cayman Chemical Company to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: March 8, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E7–5386 Filed 3–22–07; 8:45 am] The company plans to manufacture Phenylacetone to be used in the manufacture of Amphetamine for distribution to its customers. The bulk 2,5–Dimethoxyamphetamine will be used for conversion into non-controlled substances. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of ISP Freetown Fine Chemicals, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated ISP Freetown Fine Chemicals, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: March 8, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E7–5395 Filed 3–22–07; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE BILLING CODE 4410–09–P Drug Enforcement Administration DEPARTMENT OF JUSTICE Manufacturer of Controlled Substances; Notice of Registration Drug Enforcement Administration By Notice dated November 21, 2006, and published in the Federal Register on December 1, 2006, (71 FR 69591), JFC Technologies, LLC., 100 W. Main Street, Bound Brook, New Jersey 08805, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule II: Manufacturer of Controlled Substances; Notice of Registration sroberts on PROD1PC70 with NOTICES By Notice dated November 21, 2006, and published in the Federal Register on December 1, 2006, (71 FR 69590– 69591), ISP Freetown Fine Chemicals, Inc., 238 South Main Street, Assonet, Massachusetts 02702, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II: Drug Schedule 2,5-Dimethoxyamphetamine (7396). Amphetamine (1100) .................... Phenylacetone (8501) .................. VerDate Aug<31>2005 16:41 Mar 22, 2007 I II II Jkt 211001 Drug Schedule Diphenoxylate (9170) ................... Hydrocodone (9193) ..................... II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 determined that the registration of JFC Technologies, LLC to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated JFC Technologies, LLC to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: March 8, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E7–5394 Filed 3–22–07; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated November 21, 2006, and published in the Federal Register on December 1, 2006, (71 FR 69592), Johnson Matthey, Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 08066, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II: Drug Tetrahydrocannabinols (7370) ..... Dihydromorphine (9145) ............... Difenoxin (9168) ........................... Propiram (9649) ........................... Amphetamine (1100) .................... Methamphetamine (1105) ............ Methylphenidate (1724) ................ Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Hydrocodone (9193) ..................... Meperidine (9230) ........................ Morphine (9300) ........................... Thebaine (9333) ........................... Oxymorphone (9652) ................... Alfentanil (9737) ........................... Sufentanil (9740) .......................... Fentanyl (9801) ............................ E:\FR\FM\23MRN1.SGM 23MRN1 Schedule I I I I II II II II II II II II II II II II II II II

Agencies

[Federal Register Volume 72, Number 56 (Friday, March 23, 2007)]
[Notices]
[Pages 13822-13823]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-5386]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated November 28, 2006, and published in the Federal 
Register on December 7, 2006, (71 FR 70985), Cayman Chemical Company, 
1180 East Ellsworth Road, Ann Arbor, Michigan 48108, made application 
by renewal to the Drug Enforcement Administration (DEA) to be 
registered as a bulk manufacturer of the basic classes of controlled 
substances listed in schedule I:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Marihuana (7360)...........................  I
Tetrahydrocannabinols (7370)...............  I
------------------------------------------------------------------------


[[Page 13823]]

    The company plans to manufacture small quantities of marihuana 
derivatives for research purposes. In reference to drug code 7360 
(Marihuana), the company plans to bulk manufacture cannabidiol. In 
reference to drug code 7370 (Tetrahydrocannabinols), the company will 
manufacture a synthetic THC. No other activity for this drug code is 
authorized for this registration.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Cayman Chemical Company to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Cayman Chemical Company to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with State and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic classes of controlled substances listed.

    Dated: March 8, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E7-5386 Filed 3-22-07; 8:45 am]
BILLING CODE 4410-09-P